Your trusted destination for CME, CPD & Medical Education across the Middle East.
Likang Life Sciences
Shannon Cheung is a biotechnology and life-sciences entrepreneur and executive serving as Co-Founder and Vice Chairman of Likang Life Sciences. His work focuses on the development of innovative technologies in areas including personalized cancer treatment, genomics, neoantigen discovery and advanced immunotherapy. He has described Likang's work as centered on personalized cancer vaccines and cell therapies. His participation at the Summit represents the biotechnology and precision-oncology dimension of the Future Health program, particularly its focus on translating advances in genomics and molecular biology into individualized therapies.
Shannon Cheung, also known as Cheung Wing Hong Shannon, is a Hong Kong-based entrepreneur, investor, and venture builder with more than 20 years of experience in investment, corporate finance, banking, and business development. He is the founder and chairman of Averest Capital Group, through which he supports emerging businesses, provides strategic guidance, and helps companies secure financing and expand into new markets.
Throughout his career, Cheung has developed experience across multiple industries, including biotechnology, life sciences, healthcare technology, financial technology, esports, digital media, and internet services. His work combines investment expertise with a focus on building innovative companies and supporting entrepreneurs as they develop and commercialize new technologies.
One of his significant areas of involvement is biotechnology and precision medicine through Likang Life Sciences, where he serves as co-founder and vice chairman. The company focuses on advanced cancer-treatment technologies, including personalized neoantigen messenger RNA (mRNA) cancer vaccines and cell therapies. These approaches aim to develop treatments tailored to the biological characteristics of individual patients and their tumors.
Likang Life Sciences has attracted attention for its work on personalized cancer vaccines. Its neoantigen mRNA vaccine program achieved an important regulatory milestone in China in March 2023, when it received authorization to enter clinical trials from the National Medical Products Administration. In February 2025, the company also received U.S. Food and Drug Administration clearance for an Investigational New Drug application, according to publicly available professional biographies.
Beyond biotechnology, Cheung has co-founded and supported businesses in gaming, esports, sports media, and financial technology. His entrepreneurial portfolio includes Hero Games, Hero Esports, All Football, and DIB Group. Through these ventures, he has contributed to the development and growth of businesses operating in rapidly evolving technology-driven industries.
Before establishing Averest Capital Group, Cheung held senior positions at HSBC, including Managing Director of Global Banking and Chief Representative of the bank's Securities Business Beijing Representative Office. His responsibilities included originating business opportunities in mainland China, advising on initial public offerings, facilitating equity-related transactions, supporting mergers and acquisitions, and working on high-yield bond issuance.
Cheung has also been recognized for his public and community service in Hong Kong. He was awarded the Medal of Honour in 2014 and appointed a Justice of the Peace in 2019.
His professional background brings together financial services, entrepreneurship, strategic investment, and biotechnology development. His involvement with Likang Life Sciences is particularly relevant to the advancement of precision oncology, personalized cancer vaccines, and emerging therapeutic technologies.
1. Medal of Honour, Hong Kong — 2014
Recognized by the Hong Kong government for public and community service.
2. Justice of the Peace, Hong Kong — 2019
Appointed in recognition of his public-service contributions.
3. Founder and Chairman of Averest Capital Group
Established an investment and venture-building platform supporting businesses across multiple industries.
4. Co-Founder and Vice Chairman of Likang Life Sciences
Contributed to the leadership of a biotechnology company developing personalized cancer vaccines and advanced therapeutic technologies.
5. Contribution to Personalized Cancer Vaccine Development
Associated with the development of a neoantigen mRNA cancer vaccine program that achieved important regulatory milestones in China in 2023 and the United States in 2025.
6. Contribution to Technology and Gaming Entrepreneurship
Co-founded businesses spanning gaming, esports, football media, and financial technology.
7. Involvement in a Major Esports Investment Transaction
Helped advise and support VSPO in securing an approximately US$265 million investment from Savvy Games Group in 2023.
8. International Investment Industry Recognition
Participated as a speaker at the Milken Institute's Global Investors' Symposium in Hong Kong in 2025 and 2026.
Averest Capital Group
Position: Founder and Chairman; also identified as Chairman and CEO in professional speaker biographies.
Focus: Investment, venture building, corporate strategy, and business development.
Likang Life Sciences
Position: Co-Founder and Vice Chairman.
Focus: Biotechnology, personalized cancer vaccines, neoantigen research, and advanced cancer therapies.
Hero Games
Position: Co-Founder.
Focus: Video game development and gaming industry investment.
Hero Esports (formerly VSPO)
Professional involvement: Co-founder and investor; advised and assisted the company in a major investment transaction in 2023.
Focus: Esports and competitive gaming.
All Football
Position: Co-Founder.
Focus: Digital football media and sports information technology.
DIB Group
Position: Co-Founder.
Focus: Financial technology, asset management, big data, and artificial intelligence.
Shannon Cheung is an entrepreneur, investor, and venture builder with more than two decades of experience in investment, banking, corporate finance, and technology-driven businesses. As founder and chairman of Averest Capital Group and co-founder and vice chairman of Likang Life Sciences, he has developed a portfolio spanning financial services, biotechnology, gaming, esports, digital media, and financial technology.
His career combines senior financial-sector leadership with entrepreneurship and strategic investment. His involvement in personalized cancer vaccine development is particularly relevant to the biotechnology and precision-oncology sectors, while his public-service recognition includes the Hong Kong Medal of Honour in 2014 and appointment as a Justice of the Peace in 2019.

dmg events
dmg events